Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-Ignyta to explore strategic options for Taladegib through amendment of Taladegib license agreement with Lilly

By: Reuters: Company News
* Ignyta announces exploration of strategic options for Taladegib, enabled by amendment of Taladegib license agreement with Lilly
Related Stocks:
Eli Lilly
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.